- Patent Title: Injectable composition for delivery of a biologically active agent
-
Application No.: US16092636Application Date: 2017-04-11
-
Publication No.: US10905649B2Publication Date: 2021-02-02
- Inventor: Mohammad Al Kobaisi , David E. Mainwaring
- Applicant: CAPSULAR TECHNOLOGIES PTY LTD
- Applicant Address: AU Notting Hill
- Assignee: CAPSULAR TECHNOLOGIES PTY LTD
- Current Assignee: CAPSULAR TECHNOLOGIES PTY LTD
- Current Assignee Address: AU Notting Hill
- Agency: Foley & Lardner LLP
- Priority: AU2016901365 20160412,AU2016903682 20160913
- International Application: PCT/AU2017/050316 WO 20170411
- International Announcement: WO2017/177265 WO 20171019
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K39/00 ; A61K39/39 ; A61K9/107 ; A61K9/16 ; A61K9/50 ; A61K38/09 ; A61K9/14 ; A61K38/27 ; A61K47/36

Abstract:
The invention relates to an injectable composition for rapid and sustained delivery of a biologically active agent and to uses of the injectable composition in the treatment or prevention of a condition in a subject. The injectable composition comprises a water-in-oil emulsion having an aqueous phase dispersed in an oil phase. The aqueous phase comprises a plurality of hydrogel particles and an aqueous liquid and a biologically active agent is contained in the hydrogel particles and in the aqueous liquid.
Public/Granted literature
- US20190125661A1 INJECTABLE COMPOSITION FOR DELIVERY OF A BIOLOGICALLY ACTIVE AGENT Public/Granted day:2019-05-02
Information query